Back to CYTR Stock Lookup

CytRx (CYTR) – Press Releases

Oct 30, 2014 06:00 AM CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium
Oct 29, 2014 06:00 AM CytRx Announces Publication of Preclinical Glioblastoma Data in Neoplasia
Oct 20, 2014 06:00 AM CytRx Announces Publication of Phase 1b/2 Aldoxorubicin Clinical Data in Soft Tissue Sarcoma in Cancer, the Peer-Reviewed Journal of the American Cancer Society
Oct 17, 2014 06:00 AM CytRx to Present Data from Global Phase 2b Clinical Trial of Aldoxorubicin in First-Line Soft Tissue Sarcoma at 2014 CTOS Annual Meeting
Oct 16, 2014 06:00 AM CytRx Appoints Steven A. Kriegsman as Chairman of the Board
Oct 13, 2014 06:00 AM CytRx Launches Discovery Laboratory to Develop Albumin-Binding Anti-Cancer Drug Platform
Oct 9, 2014 06:00 AM CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Gemcitabine in Patients with Metastatic Solid Tumors
Oct 7, 2014 04:05 PM CytRx Announces Unexpected Passing of Chairman Max Link, PhD
Sep 30, 2014 06:00 AM CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer
Sep 29, 2014 06:00 AM CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer
Sep 26, 2014 06:00 AM CytRx Updates Presentation Time at BioCentury's 2014 NewsMakers in the Biotech Industry Conference
Sep 22, 2014 06:00 AM CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress
Sep 19, 2014 06:00 AM CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference
Sep 15, 2014 03:23 PM Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities Fraud Lawsuit: Secondary Offering Shareholders (January 31, 2014) Should Inquire For More Information
Sep 15, 2014 09:01 AM Zeldes & Haeggquist, LLP Continues Investigation of CytRx Corporation
Sep 9, 2014 06:00 AM CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Ifosfamide/Mesna as First-Line Treatment in Patients with Advanced Sarcomas
Sep 5, 2014 06:00 AM CytRx Updates Presentation Time at Aegis 2014 Healthcare & Technology Conference
Sep 2, 2014 06:00 AM CytRx to Present at Upcoming Investor Conferences in New York City and Las Vegas
Aug 11, 2014 08:00 AM Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
Aug 7, 2014 06:00 AM Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma Highlighted in The Lancet Oncology
Aug 6, 2014 06:00 AM CytRx Reports 2014 Second Quarter Financial Results

Back to CYTR Stock Lookup